Oxford BioDynamicsLSE:OBD -21.51% Market Cap is £5.79 Mil as of Jun. 28, 2026. The stock has 4 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Oxford BioDynamics ranks worse than 85.78% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Oxford BioDynamics's share price for the quarter that ended in Sep. 2025 was £0.00475. Oxford BioDynamics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 1,957.58 Mil. Therefore, Oxford BioDynamics's market cap for the quarter that ended in Sep. 2025 was £9.30 Mil.
Oxford BioDynamics's quarterly market cap
declined
from Sep. 2024 (£10.04 Mil) to Mar. 2025 (£9.30 Mil) but then
stayed the same
from Mar. 2025 (£9.30 Mil) to Sep. 2025 (£9.30 Mil).
Oxford BioDynamics's annual market cap
declined
from Sep. 2023 (£74.85 Mil) to Sep. 2024 (£10.04 Mil) and
declined
from Sep. 2024 (£10.04 Mil) to Sep. 2025 (£9.30 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Oxford BioDynamics's Enterprise Value for Today is £9.51 Mil.
Oxford BioDynamics (LSE:OBD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Oxford BioDynamics Market Cap Related Terms
Oxford BioDynamics Market Cap Historical Data
* Premium members only.
The historical data trend for Oxford BioDynamics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Oxford BioDynamics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford BioDynamics Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's Market Cap distribution charts can be found below:
* The bar in red indicates where Oxford BioDynamics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Oxford BioDynamics's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford BioDynamics (LSE:OBD) has a Market Cap of £5.79 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Oxford BioDynamics and its competitors. According to the industry distribution chart, Oxford BioDynamics ranks #187 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 85.8%.
Is Oxford BioDynamics' Market Cap too high?
Oxford BioDynamics' current Market Cap is £5.79 Mil. Based on the distribution chart, Oxford BioDynamics ranks #187 out of 218 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Oxford BioDynamics' Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Oxford BioDynamics ranks #187 out of 218 companies for Market Cap. This places Oxford BioDynamics in the lower half of its industry. The industry median Market Cap is 55.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 55.55, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Oxford BioDynamics and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 55.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford BioDynamics's current Market Cap is £5.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (LSE:OBD) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 93.3% below its estimated fair value. The current Market Cap is £5.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Oxford BioDynamics (LSE:OBD), the current Market Cap is £5.79 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:OBD has been successfully added to your 